Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Finished Goods (2022 - 2025)

Tenon Medical has reported Finished Goods over the past 4 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Finished Goods rose 76.58% year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.0 million, up 76.58%, while the annual FY2025 figure was $1.0 million, 76.58% up from the prior year.
  • Finished Goods for Q4 2025 was $1.0 million at Tenon Medical, up from $585000.0 in the prior quarter.
  • Over five years, Finished Goods peaked at $1.0 million in Q4 2025 and troughed at $406000.0 in Q4 2022.
  • A 4-year average of $639000.0 and a median of $558500.0 in 2023 define the central range for Finished Goods.
  • Biggest five-year swings in Finished Goods: rose 9.96% in 2024 and later surged 76.58% in 2025.
  • Year by year, Finished Goods stood at $406000.0 in 2022, then skyrocketed by 31.03% to $532000.0 in 2023, then rose by 9.96% to $585000.0 in 2024, then skyrocketed by 76.58% to $1.0 million in 2025.
  • Business Quant data shows Finished Goods for TNON at $1.0 million in Q4 2025, $585000.0 in Q4 2024, and $532000.0 in Q4 2023.